Cambridge Investment Research Advisors, Inc. Novavax Inc Transaction History

Cambridge Investment Research Advisors, Inc.

$26 Billion
Q1 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Novavax Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 15,175 shares of NVAX stock, worth $183,010. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,175

Previous 19,232 21.1%

Holding current value

$183,010

Previous $92,000 20.65%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$3.76 - $6.02 $15,254 - $24,423	-4,057 Reduced 21.1%	15,175 $73,000
Q4 2023 Feb 09, 2024	SELL	$4.8 - $7.67 $47,980 - $76,669	-9,996 Reduced 34.2%	19,232 $92,000
Q3 2023 Oct 24, 2023	BUY	$6.81 - $9.74 $199,042 - $284,680	29,228 New	29,228 $212,000
Q1 2023 May 11, 2023	BUY	$5.76 - $12.48 $71,608 - $155,151	12,432 New	12,432 $86,000
Q3 2022 Oct 17, 2022	SELL	$18.2 - $76.12 $153,225 - $640,854	-8,419 Reduced 44.99%	10,294 $187,000

Q2 2022 Jul 13, 2022	BUY	$36.28 - $75.29 $154,988 - $321,638	4,272 Added 29.58%	18,713 $962,000
Q1 2022 May 12, 2022	BUY	$69.73 - $142.9 $181,925 - $372,826	2,609 Added 22.05%	14,441 $1.06 Million
Q4 2021 Feb 03, 2022	BUY	$134.56 - $217.97 $445,797 - $722,134	3,313 Added 38.89%	11,832 $1.69 Million
Q3 2021 Nov 02, 2021	BUY	$177.8 - $270.58 $108,991 - $165,865	613 Added 7.75%	8,519 $1.77 Million
Q2 2021 Aug 10, 2021	BUY	$121.0 - $257.67 $223,245 - $475,401	1,845 Added 30.44%	7,906 $1.68 Million
Q1 2021 May 07, 2021	SELL	$112.98 - $319.93 $373,398 - $1.06 Million	-3,305 Reduced 35.29%	6,061 $1.1 Million
Q4 2020 Feb 04, 2021	SELL	$78.74 - $139.5 $77,165 - $136,710	-980 Reduced 9.47%	9,366 $1.04 Million
Q3 2020 Oct 29, 2020	BUY	$79.44 - $178.51 $219,731 - $493,758	2,766 Added 36.49%	10,346 $1.12 Million
Q2 2020 Jul 27, 2020	BUY	$13.86 - $83.61 $105,058 - $633,763	7,580 New	7,580 $631,000

Others Institutions Holding NVAX

# of Institutions

243

Shares Held

76.1M

Call Options Held

5.06M

Put Options Held

7.19M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $943M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Novavax Inc Transaction History